John Gurley, MD
Cardiovascular Disease · Lexington, KYNPI 1740299502
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Medtronic at 40.4% of the total. Reporting peaked in 2023 at $9,801 and has fallen 60.5% since, to $3,869 in 2025. Among cardiovascular disease clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 173 payments — averaging $121.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$9K
- Ancora Heart, Inc.$2K
- Philips North America LLC$2K
- Abbott$2K
- Boston Scientific$1K
- Edwards Lifesciences$1K
- plus $4K from 17 others
Across 75 payments — averaging $2001.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$106K
- W. L. Gore & Associates, Inc.$34K
- Atricure, Inc.$7K
- Surmodics, Inc.$2K
What the payments were for
- Speaking & faculty fees$5,50026%
- Travel & lodging$4,57022%
- Food & beverage$11,01152%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 19 | $8,514 |
| Ancora Heart, Inc. | 9 | $2,345 |
| Philips North America LLC | 49 | $2,188 |
| Abbott | 21 | $1,538 |
| Boston Scientific | 19 | $1,336 |
| Edwards Lifesciences | 14 | $1,190 |
| Abiomed | 9 | $819 |
| Shockwave Medical, Inc | 3 | $477 |
| W. L. Gore & Associates, Inc. | 6 | $469 |
| EKOS Corporation | 4 | $406 |
| Penumbra, Inc. | 2 | $294 |
| Janssen Scientific Affairs, LLC | 4 | $263 |
| Johnson & Johnson | 2 | $225 |
| Cardiac Dimensions, Inc. | 2 | $168 |
| Atricure, Inc. | 1 | $160 |
| Michigan Critical Care Consultants, Inc. | 1 | $126 |
| Biotronik Inc. | 1 | $114 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $103 |
| Angiodynamics, Inc. | 2 | $96 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $78 |
| Cook Medical LLC | 1 | $74 |
| ZOLL Respicardia, Inc. | 1 | $74 |
| Biosense Webster, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MC3 Crescent Jugular Dual Lumen Catheter$7,653
- AccuCinch$2,247
- EKOSONIC$514
- SAPIEN 3 Ultra RESILIA$484
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$477
- (9124) LM Undivided$424
- Impella$380
- XARELTO$350
- Indigo$305
- Legacy$293
- COREVALVE EVOLUT R$281
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$272
- WATCHMAN Access System$236
- NAVITOR$192
- ATRICLIP LAA EXCLUSION SYSTEM$160
- Indigo System$142
- Micra$130
- Melody$128
- CoreValve Evolut$127
- ELUVIA$126
How this compares
$21,081 in reported general payments places this provider in the 90th percentile of 258 cardiovascular disease providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 105 | $104,251 |
| XareltoRivaroxaban | 35 | $19,106 |
| FarxigaDapagliflozin Propanediol | 12 | $12,091 |
| Ranolazine ErRanolazine | 14 | $1,048 |
| Metoprolol Tartrate | 71 | $807 |
| Metoprolol Succinate | 57 | $772 |
| Atorvastatin Calcium | 79 | $635 |
| Carvedilol | 36 | $535 |
| Losartan Potassium | 29 | $436 |
| Warfarin Sodium | 27 | $401 |
| Nebivolol Hcl | 12 | $331 |
| Rosuvastatin Calcium | 19 | $306 |
| ClopidogrelClopidogrel Bisulfate | 31 | $243 |
| Pantoprazole Sodium | 21 | $233 |
| Amlodipine Besylate | 17 | $126 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $225 | $19,10635 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 258 cardiovascular disease providers in Kentucky.
Other cardiovascular disease in Lexington
- William SkinnerLexington$312K
- David MoliternoLexington$115K
- Andrew LeventhalLexington$43K
- Suresh SharmaLexington$15K
- James CragerLexington$12K
- Kevin ScullyLexington$9K
- Nathan KustererLexington$8K
- Amir PirachaLouisville$530K
- Dinesh KalraLouisville$316K
- Prabodh MehtaElizabethtown$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.